Basic Information
Basic information for LINC00917-217-45aa
Peptide Name LINC00917-217-45aa
Genome Position chr16:86332475-86332609[-]
Species Human
Peptide Sequence MQLLTLKIKGLQTKERGSLWKRQGIDAALGPPEGTSPVNTLILAQ
Peptide Length 45
Unique No (LINC00917-201-45aa,LINC00917-202-45aa,LINC00917-206-45aa,LINC00917-207-45aa,LINC00917-208-45aa,LINC00917-209-45aa,LINC00917-210-45aa,LINC00917-211-45aa,LINC00917-212-45aa,LINC00917-213-45aa,LINC00917-214-45aa,LINC00917-215-45aa,LINC00917-216-45aa)
Grand Average of Hydropathicity -0.2067
Relative Molecular Mass 5665.52
Experimental Evidences no
lncRNA ID/Name ENSG00000168367;LINC00917
Transcript ID/Name ENST00000670118;LINC00917-217
Transcript Length 2513
Coding Ability 0.3645
DNA Sequence Corresponding to Peptide ATGCAACTGCTGACTTTGAAGATTAAGGGGCTACAAACCAAGGAACGTGGTAGTCTCTGGAAAAGACAAGGAATAGACGCTGCGTTGGGGCCACCAGAAGGAACCAGCCCTGTCAACACCCTAATTTTAGCCCAG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :